288
Participants
Start Date
October 10, 2022
Primary Completion Date
August 31, 2024
Study Completion Date
December 31, 2024
ClearEdge device
ClearEdge tissue imaging device uses a new technology to detect tissue abnormalities at the surgical margins of a surgically excised breast tissue specimen. Adding the use of the imaging device has the potential to assist the surgeon in identifying DCIS or invasive cancer involved margins of the excised specimen.
RECRUITING
UCSF Medical Center at Mission Bay, San Francisco
Lead Sponsor
LS BioPath
INDUSTRY